Eli Lilly and Company

Novo Nordisk A/S

China has entered the race in the market of weight loss drugs: several companies from China have presented their products that may become competitors to Ozempic, Mounjaro and other hits from Novo Nordisk and Eli Lilly. The first of these received regulatory approval in June. In general, Chinese biotech has survived the prolonged "nuclear winter" and is now actively developing. What should an investor know about it?

The end of nuclear winter and tens of percent growth: how China is growing its pharma giants


JPMorgan Chase & Co.

The Goldman Sachs Group, Inc.

BOEING CO CEDEAR EACH 6 REP 1

The Wall Street Journal <a href="https://www.wsj.com/economy/central-banking/trump-next-federal-reserve-chair-powell-d3edcb9c">reported</a> last week that U.S. President Donald Trump could name a nominee for Fed chairman as early as September-October or even this summer.&nbsp;

Cut rates, be proactive and look good: How Trump is picking a new Fed chief

Trump Media & Technology Group Corp.

Last week, President Trump's family announced several projects at once - the creation of a mobile operator and the production of an "all-American" smartphone, as well as the launch of a cryptocurrency exchange fund. Do these projects have potential?

Ekaterina Komarova

Writes about:

PepsiCo, Inc.

Delta Air Lines, Inc.

Meta Platforms, Inc.

Articles: 3

The end of nuclear winter and tens of percent growth: how China is growing its pharma giants

Cut rates, be proactive and look good: How Trump is picking a new Fed chief

Made by Trump: what investors should know about the new projects of the US President's family